Medical Health & Life Science Research News

Global birch pollen allergy pipeline therapeutics market review H2 2017 published by leading research firm

Global birch pollen allergy pipeline therapeutics market review H2 2017 published by leading research firm

The Birch Pollen Allergy pipeline guide reviews key companies involved in Birch Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.

- Agency -.

The Birch Pollen Allergy pipeline covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Key players are ALK-Abello A/S, Allergy Therapeutics Plc, Anergis SA, Biomay AG, HAL Allergy BV, Laboratorios LETI SL

Access Complete Report On Birch Pollen Allergy - Pipeline Review, H2 2017: www.reportsnreports.com/purchase.aspx?name=1132624 .

- Agency -.

Drug Profiles : Allergen for Allergic Rhinitis and Allergic Rhino-Conjunctivitis, AllerT, BM-31, PL-102, Pollinex Quattro Tree

Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose.

Predisposing factors include age, family history and other allergies. Treatment includes drugs belonging to class of antihistamines.

Get Birch Pollen Allergy Pipeline Review Report [email protected] www.reportsnreports.com/contacts/d…aspx?name=1132624 .

The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Unknown stages are 2, 3, 5 and 1 respectively.

Birch Pollen Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

List of Tables
Number of Products under Development for Birch Pollen Allergy, H2 2017
Number of Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Birch Pollen Allergy - Pipeline by ALK-Abello A/S, H2 2017
Birch Pollen Allergy - Pipeline by Allergy Therapeutics Plc, H2 2017
Birch Pollen Allergy - Pipeline by Anergis SA, H2 2017
Birch Pollen Allergy - Pipeline by Biomay AG, H2 2017
Birch Pollen Allergy - Pipeline by HAL Allergy BV, H2 2017
Birch Pollen Allergy - Pipeline by Laboratorios LETI SL, H2 2017
Birch Pollen Allergy - Dormant Projects, H2 2017
Birch Pollen Allergy - Discontinued Products, H2 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.